These observations suggest that the relative extent by which the SNPs modify breast cancer risks in BRCA1 and BRCA2 mutation carriers is somewhat smaller than that in the general population, perhaps because a subset of SNPs do not combine multiplicatively with mutation status. The gene discussed is BRCA2; the disease is breast cancer.